Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Rommel

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|March 18, 2006
Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensingEmilio Hirsch, Giuseppe Lembo, Giuseppe Montrucchio, et al.
Proteomics|October 11, 2008
Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocationNicolas Favre, Montserrat Camps, Christian Arod, et al.
Seminars in Immunology|December 24, 2002
Strategies for chemokine antagonists as therapeuticsAmanda E I Proudfoot, Christine A Power, Christian Rommel, et al.
The Journal of Biological Chemistry|July 31, 2004
MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alphaMarco Castelli, Montserrat Camps, Corine Gillieron, et al.
Blood|September 24, 2005
Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cellsAntonio Bilancio, Klaus Okkenhaug, Montserrat Camps, et al.
Biochemistry|July 27, 2005
The DRY motif as a molecular switch of the human oxytocin receptorNicolas Favre, Francesca Fanelli, Marc Missotten, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2007
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitmentChiara Ferrandi, Vittoria Ardissone, Pamela Ferro, et al.
Breast Cancer Research and Treatment|October 23, 2012
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft modelsYesim Gökmen-Polar, Yi Liu, Rachel A Toroni, et al.
The American Journal of Pathology|March 22, 2012
PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritisBeatrix Bartok, David L Boyle, Yi Liu, et al.
Blood|July 29, 2008
PI3Kgamma (PI3Kgamma) is essential for efficient induction of CXCR3 on activated T cellsJoseph Barbi, Hannah E Cummings, Bao Lu, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|March 18, 2006
Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensingEmilio Hirsch, Giuseppe Lembo, Giuseppe Montrucchio, et al.
Proteomics|October 11, 2008
Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocationNicolas Favre, Montserrat Camps, Christian Arod, et al.
Seminars in Immunology|December 24, 2002
Strategies for chemokine antagonists as therapeuticsAmanda E I Proudfoot, Christine A Power, Christian Rommel, et al.
The Journal of Biological Chemistry|July 31, 2004
MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alphaMarco Castelli, Montserrat Camps, Corine Gillieron, et al.
Blood|September 24, 2005
Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cellsAntonio Bilancio, Klaus Okkenhaug, Montserrat Camps, et al.
Biochemistry|July 27, 2005
The DRY motif as a molecular switch of the human oxytocin receptorNicolas Favre, Francesca Fanelli, Marc Missotten, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2007
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitmentChiara Ferrandi, Vittoria Ardissone, Pamela Ferro, et al.
Breast Cancer Research and Treatment|October 23, 2012
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft modelsYesim Gökmen-Polar, Yi Liu, Rachel A Toroni, et al.
The American Journal of Pathology|March 22, 2012
PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritisBeatrix Bartok, David L Boyle, Yi Liu, et al.
Blood|July 29, 2008
PI3Kgamma (PI3Kgamma) is essential for efficient induction of CXCR3 on activated T cellsJoseph Barbi, Hannah E Cummings, Bao Lu, et al.
Pageof 6